Treatment of Polycythemia Vera in Patients Under Age 60 with No History of Thrombosis
This page covers the management approach for a specific low-risk subset of polycythemia vera: patients who are younger than 60 years and have no prior history of thrombosis. The therapeutic strategy in this group differs from higher-risk presentations.
Clinical scenario
Low-risk polycythemia vera — patients younger than 60 years with no history of thrombosis. Age under 60 is a defining feature of this risk category, shaping the intensity and composition of the treatment approach.
Treatment approach
Management in this low-risk group centres on addressing cardiovascular risk factors alongside targeted pharmacologic and procedural interventions. The full structured regimen — including sequencing and specific components — is available via the protocol.
Complete regimen details, including all components and clinical decision points, are in the full protocol below.
References
- Low Risk – Patients who have PV younger than 60 years with no history of thrombosis.
- Manage cardiovascular risk factors
- Low-dose aspirin (80-100 mg per day)
- Phlebotomy
View source ↗